Works matching DE "EXEMESTANE"
Results: 86
Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2017, v. 42, n. 5, p. 547, doi. 10.1111/jcpt.12569
- By:
- Publication type:
- Article
Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 18, p. 2037, doi. 10.1007/s40265-017-0849-3
- By:
- Publication type:
- Article
Artificial sex reversal of white grouper (Epinephelus aeneus) utilizing aromatase inhibitor (Fadrozole).
- Published in:
- Aquaculture Research, 2019, v. 50, n. 5, p. 1539, doi. 10.1111/are.14030
- By:
- Publication type:
- Article
Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines.
- Published in:
- Chemistry Central Journal, 2013, v. 7, n. 1, p. 1, doi. 10.1186/1752-153X-7-57
- By:
- Publication type:
- Article
The Prognostic Values of Androgen Receptor in Breast Cancer: A Hospital-Based Retrospective and Propensity Score--Matched Cohort.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2023, v. 147, n. 9, p. 1075, doi. 10.5858/arpa.2021-0590-OA
- By:
- Publication type:
- Article
Evaluating the 21-gene assay Recurrence Score as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 607, doi. 10.1007/s10147-013-0614-x
- By:
- Publication type:
- Article
A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 4, p. 667, doi. 10.1111/bcp.12828
- By:
- Publication type:
- Article
Poly( D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.
- Published in:
- Journal of Microencapsulation, 2013, v. 30, n. 5, p. 432, doi. 10.3109/02652048.2012.746749
- By:
- Publication type:
- Article
DETERMINATION OF LETROZOLE, ANASTROZOLE AND EXEMESTANE BY CAPILLARY ZONE ELECTROPHORESIS.
- Published in:
- Studia Universitatis Babes-Bolyai, Chemia, 2017, v. 62, n. 3, p. 251, doi. 10.24193/subbchem.2017.3.21
- By:
- Publication type:
- Article
Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study.
- Published in:
- BMC Health Services Research, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12913-015-0971-4
- By:
- Publication type:
- Article
Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-239
- By:
- Publication type:
- Article
Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 1, p. 117, doi. 10.1007/s00432-013-1551-9
- By:
- Publication type:
- Article
Tucidinostat Plus Exemestane as a Neoadjuvant in Early-Stage, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e763, doi. 10.1093/oncolo/oyae033
- By:
- Publication type:
- Article
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor‐Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care‐BC): A Randomized Controlled Phase III Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e223, doi. 10.1634/theoncologist.2019-0382
- By:
- Publication type:
- Article
Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 893, doi. 10.1634/theoncologist.2018-0407
- By:
- Publication type:
- Article
Impact of Comorbidities and Age on Cause‐Specific Mortality in Postmenopausal Patients with Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. e467, doi. 10.1634/theoncologist.2018-0010
- By:
- Publication type:
- Article
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 648, doi. 10.1634/theoncologist.2016-0461
- By:
- Publication type:
- Article
Clinical Trial Results. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1126, doi. 10.1634/theoncologist.2014-0306
- By:
- Publication type:
- Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 346, doi. 10.1634/theoncologist.2014-0022
- By:
- Publication type:
- Article
Validation of RP-HPLC method for determination of exemestane and its impurities in pharmaceutical dosage forms.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 213
- By:
- Publication type:
- Article
Letrozole-Induced Very Early Systemic Sclerosis in a Patient With Breast Cancer: A Case Report.
- Published in:
- Archives of Rheumatology, 2014, v. 29, n. 2, p. 126, doi. 10.5606/ArchRheumatol.2014.3429
- By:
- Publication type:
- Article
Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 3044, doi. 10.1002/cam4.1600
- By:
- Publication type:
- Article
Breast cancer with bony metastases confined to the left leg.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Advances in Association of Estrogen and Human Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2015, v. 18, n. 5, p. 315, doi. 10.3779/j.issn.1009-3419.2015.05.10
- By:
- Publication type:
- Article
Grip Strength in Women Being Treated for Breast Cancer and Receiving Adjuvant Endocrine Therapy: Systematic Review.
- Published in:
- Physical Therapy, 2017, v. 97, n. 9, p. 904, doi. 10.1093/ptj/pzx069
- By:
- Publication type:
- Article
Triggering of Suicidal Erythrocyte Death by Exemestane.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 41, n. 5, p. 1, doi. 10.1159/000477224
- By:
- Publication type:
- Article
OFS, Examestane Improve Recurrence-Related Outcomes in Premenopausal Breast Cancer.
- Published in:
- ONS Voice, 2023, p. 1
- By:
- Publication type:
- Article
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 9, n. 3, p. 255, doi. 10.3892/mco.2018.1672
- By:
- Publication type:
- Article
Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations.
- Published in:
- BioImpacts, 2017, v. 7, n. 4, p. 227, doi. 10.15171/bi.2017.27
- By:
- Publication type:
- Article
Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 11, p. 1509, doi. 10.1089/jwh.2023.0971
- By:
- Publication type:
- Article
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 3, p. 93, doi. 10.1159/000485566
- By:
- Publication type:
- Article
Lipid-based dispersions of exemestane for improved dissolution rate and intestinal permeability: in vitro and ex vivo characterization.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2017, v. 45, n. 5, p. 917, doi. 10.1080/21691401.2016.1193023
- By:
- Publication type:
- Article
Exemestane encapsulated vitamin E-TPGS–polymeric nanoparticles: preparation, optimization, characterization, and in vitro cytotoxicity assessment.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2017, v. 45, n. 3, p. 522, doi. 10.3109/21691401.2016.1163714
- By:
- Publication type:
- Article
Cancer Diagnostic and Predictive Biomarkers 2018.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/3879015
- By:
- Publication type:
- Article
Guideline adds aromatase inhibitor for breast cancer prevention.
- Published in:
- Formulary, 2013, v. 48, n. 8, p. 243
- Publication type:
- Article
Falsely elevated serum oestradiol due to exemestane therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effectiveness of the aromatase (P450 Arom) inhibitors Letrozole and Exemestane for masculinization of red tilapia (Oreochromis spp.).
- Published in:
- Revista Colombiana de Ciencias Pecuarias, 2014, v. 27, n. 1, p. 47, doi. 10.17533/udea.rccp.324878
- By:
- Publication type:
- Article
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1793, doi. 10.1177/10781552231185855
- By:
- Publication type:
- Article
Exemestane induced cholestatic liver injury – A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1029, doi. 10.1177/1078155220957726
- By:
- Publication type:
- Article
Lack of everolimus diffusion in pleural fluid during pleural progression of breast cancer: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 1, p. 235, doi. 10.1177/1078155220927771
- By:
- Publication type:
- Article
Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1780, doi. 10.1177/1078155220910252
- By:
- Publication type:
- Article
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
- Published in:
- Breast Journal, 2019, v. 25, n. 6, p. 1310, doi. 10.1111/tbj.13474
- By:
- Publication type:
- Article
Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early‐stage hormone receptor‐positive breast cancer: A meta‐analysis of randomized controlled trials.
- Published in:
- Breast Journal, 2019, v. 25, n. 6, p. 1297, doi. 10.1111/tbj.13465
- By:
- Publication type:
- Article
A SIMPLE, SENSITIVE, SELECTIVE AND HIGH THROUGHPUT LIQUIDCHROMATOGRAPHY/TANDEM MASS SPECTROMETRY (LC/MS/MS)ASSAY OF EXEMESTANEIN HUMAN PLASMA.
- Published in:
- International Journal of Pharmaceutical, Chemical & Biological Sciences, 2015, v. 5, n. 2, p. 463
- By:
- Publication type:
- Article
Ovarian function suppression is beneficial in some premenopausal women with early breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Exemestane loaded polymeric nanoparticles for oral delivery.
- Published in:
- International Journal of Nano Dimension, 2015, v. 6, n. 4, p. 417
- By:
- Publication type:
- Article
Management of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment options.
- Published in:
- Cancer Management & Research, 2015, v. 7, p. 37, doi. 10.2147/CMAR.S72592
- By:
- Publication type:
- Article
Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Application to Human Pharmacokinetics Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0118553
- By:
- Publication type:
- Article
Progression-free or overall survival...revisited in BOLERO-2.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor--Positive Early-Stage Breast Cancer... [including commentary by ANN H. PARTRIDGE].
- Published in:
- Oncology (08909091), 2015, v. 29, n. 7, p. 473
- By:
- Publication type:
- Article